GR3005370T3 - - Google Patents

Info

Publication number
GR3005370T3
GR3005370T3 GR920401704T GR920401704T GR3005370T3 GR 3005370 T3 GR3005370 T3 GR 3005370T3 GR 920401704 T GR920401704 T GR 920401704T GR 920401704 T GR920401704 T GR 920401704T GR 3005370 T3 GR3005370 T3 GR 3005370T3
Authority
GR
Greece
Prior art keywords
beta
compounds
androst
cyclopropyloxy
simmons
Prior art date
Application number
GR920401704T
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GR3005370T3 publication Critical patent/GR3005370T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C07J1/0029—Ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/003—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring the S atom directly linked to a ring carbon atom of the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GR920401704T 1987-04-22 1992-08-06 GR3005370T3 (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/041,170 US4891367A (en) 1987-04-22 1987-04-22 17β-(cyclopropyloxy)androst-5-en-3β-ol and related compounds useful as C17-20 lyase inhibitors

Publications (1)

Publication Number Publication Date
GR3005370T3 true GR3005370T3 (el) 1993-05-24

Family

ID=21915121

Family Applications (1)

Application Number Title Priority Date Filing Date
GR920401704T GR3005370T3 (el) 1987-04-22 1992-08-06

Country Status (20)

Country Link
US (1) US4891367A (el)
EP (1) EP0291717B1 (el)
JP (1) JP2593685B2 (el)
KR (1) KR960015036B1 (el)
CN (1) CN1024279C (el)
AT (1) ATE78487T1 (el)
AU (1) AU605575B2 (el)
CA (1) CA1309088C (el)
DE (1) DE3872938T2 (el)
DK (1) DK167766B1 (el)
ES (1) ES2051787T3 (el)
FI (1) FI87791C (el)
GR (1) GR3005370T3 (el)
HU (1) HU198508B (el)
IL (1) IL86140A (el)
NO (1) NO168892C (el)
NZ (1) NZ224287A (el)
PH (1) PH23863A (el)
PT (1) PT87293B (el)
ZA (1) ZA882715B (el)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU606677B2 (en) * 1987-04-22 1991-02-14 Merrell Dow Pharmaceuticals Inc. 17 beta -(cyclopropylimino) androst-5-EN-3 beta- Ol and related compounds useful as C17-20 lyase inhibitors
US4954488A (en) * 1989-06-14 1990-09-04 Merrell Dow Pharmaceuticals Inc. Method of treating hyperaldosteronism using 17β-cyclopropylaminoandrostene derivatives
US4966897A (en) * 1989-08-15 1990-10-30 Merrell Dow Pharmaceuticals Inc. 4-substituted 17β-(cyclopropyloxy)androst-5-en-3β-ol and related compounds useful as C17-20 lyase inhibitors
US5051534A (en) * 1990-03-22 1991-09-24 Merrell Dow Pharmaceuticals Inc. Novel cyclopropyl squalene derivatives and their use as inhibitors of cholesterol synthesis
US5102915A (en) * 1990-03-22 1992-04-07 Merrell Dow Pharmaceuticals Inc. Cyclopropyl squalene derivatives and their use as inhibitors of cholesterol synthesis
US5486511A (en) * 1993-05-25 1996-01-23 Merrell Dow Pharmaceuticals Inc. 4-amino-17β-(cyclopropyloxy)androst-4-en-3-one, 4-amino-17β-(cyclopropylamino)androst-4-en-3-one and related compounds as C17-20 lyase and 5α-reductase
US5661141A (en) * 1995-03-27 1997-08-26 Petrow; Vladimir 19-oxygenated steroids as therapeutic agents
US6365597B1 (en) 1996-02-14 2002-04-02 Aventis Pharmaceuticals Inc. 4-aza steroids
US6093389A (en) * 1997-12-01 2000-07-25 American Cyanamid Company Methods and compositions for attracting and controlling termites
WO2003039250A2 (en) * 2001-11-08 2003-05-15 Colorado State University Research Foundation Termite feeding stimulant and method for using same
WO2008157460A1 (en) 2007-06-15 2008-12-24 Cook, Kevin, M. Androstane and pregnane steroids with potent allosteric gaba receptor chloride ionophore modulating properties

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3135744A (en) * 1961-04-12 1964-06-02 Vismara Francesco Spa Cycloalkenyl ethers of 17 beta-hydroxy androstanes
CH471103A (de) * 1962-02-28 1969-04-15 Warner Lambert Pharmaceutical Verfahren zur Herstellung neuer (1'-Alkoxy)-alkyl- und cycloalkyläther von 17B-Hydroxysteroiden
US3475464A (en) * 1966-11-07 1969-10-28 Syntex Corp Process for the preparation of steroids and novel intermediates thereof
US3732209A (en) * 1971-03-15 1973-05-08 Hoffmann La Roche Novel 17beta-oxygenated cyclopropa(16alpha,17alpha)steroids
US3763146A (en) * 1972-02-03 1973-10-02 Syntex Corp Novel 17beta(tetrahydropyran-4-yloxy)steroids
US4139617A (en) * 1974-05-13 1979-02-13 Richardson-Merrell Inc. 19-Oxygenated-androst-5-enes for the enhancement of libido
US4361559A (en) * 1981-08-20 1982-11-30 E. R. Squibb & Sons, Inc. Antiinflammatory 17,17-bis (substituted thio) androstenes
US4420428A (en) * 1982-12-27 1983-12-13 E. R. Squibb & Sons, Inc. 16-Ketoandrostene-17-dithioketals
US4427592A (en) * 1983-01-31 1984-01-24 E. R. Squibb & Sons, Inc. Androstene-17-dithioketals
US4529548A (en) * 1984-05-07 1985-07-16 E. R. Squibb & Sons, Inc. 17β-(substituted thio)androstenes
AU606677B2 (en) * 1987-04-22 1991-02-14 Merrell Dow Pharmaceuticals Inc. 17 beta -(cyclopropylimino) androst-5-EN-3 beta- Ol and related compounds useful as C17-20 lyase inhibitors

Also Published As

Publication number Publication date
CA1309088C (en) 1992-10-20
HUT47305A (en) 1989-02-28
ES2051787T3 (es) 1994-07-01
FI881878A (fi) 1988-10-23
HU198508B (en) 1989-10-30
DK217488D0 (da) 1988-04-21
EP0291717B1 (en) 1992-07-22
AU1472088A (en) 1988-10-27
EP0291717A1 (en) 1988-11-23
US4891367A (en) 1990-01-02
KR880012634A (ko) 1988-11-28
ATE78487T1 (de) 1992-08-15
JP2593685B2 (ja) 1997-03-26
NO881745L (no) 1988-10-24
IL86140A (en) 1993-02-21
KR960015036B1 (ko) 1996-10-24
PT87293B (pt) 1992-08-31
DE3872938T2 (de) 1993-01-07
IL86140A0 (en) 1988-11-15
JPS63284194A (ja) 1988-11-21
FI87791B (fi) 1992-11-13
DK217488A (da) 1988-10-23
NO881745D0 (no) 1988-04-21
FI881878A0 (fi) 1988-04-21
CN1024279C (zh) 1994-04-20
DE3872938D1 (de) 1992-08-27
DK167766B1 (da) 1993-12-13
ZA882715B (en) 1988-10-17
AU605575B2 (en) 1991-01-17
CN88102175A (zh) 1988-11-16
NZ224287A (en) 1989-11-28
NO168892B (no) 1992-01-06
PT87293A (pt) 1988-05-01
NO168892C (no) 1992-04-15
FI87791C (fi) 1993-02-25
PH23863A (en) 1989-11-23

Similar Documents

Publication Publication Date Title
ZA906307B (en) 4-substituted 18beta-(cyclopropyloxy)androst-5-en-3beta-ol and related compounds useful as c17-20lyase inhibitors
HUT47307A (en) Process for producing 17beta-(cyclopropylamino)-androst-5-en-3beta-ol and its derivatives
GR3005370T3 (el)
ZA906308B (en) 4-substituted 17beta-(cyclopropylamino)androst-5-en-3beta-ol and related compounds useful as c17-20lyase inhibitors
DE3570436D1 (en) Process for the preparation of hydrogeno or halogenosilanes
DE3260086D1 (en) Process for the preparation of 4-aminobutyramide
PL254252A2 (en) Method of obtaining novel 2,3,3-trimethylcyclopentyl vinyl ether